ESCORT II CLINICAL THERMOMETRY MODULE (CTM)
K970011 · Medical Data Electronics · FLL · Jul 9, 1997 · General Hospital
Device Facts
| Record ID | K970011 |
| Device Name | ESCORT II CLINICAL THERMOMETRY MODULE (CTM) |
| Applicant | Medical Data Electronics |
| Product Code | FLL · General Hospital |
| Decision Date | Jul 9, 1997 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 880.2910 |
| Device Class | Class 2 |
| Attributes | Pediatric |
Intended Use
The Clinical Thermometry Module is intended to be used for the intermittent determination of temperature in hypothermic, normothermic or febrile children or adults. In the Normal mode, oral use in compliant patients allowing maintenance of the probe in the sublingual picket for the temperature-taking cycle, enables the predictive algorithm to determine an accurate temperature in approximately 4 seconds. Rectal use results in a predictive temperature in approximately 10 seconds. The primary use of the CTM, as an intermittent thermometer, is to take a patient's temperature at a single point in time. However, the instrument's Monitor mode also allows continuous monitoring of the patient's temperature. The CTM is a clinical grade thermometer. It is intended for use by healthcare practitioners only; typically in a hospital, clinic or mobile environment. It is not intended for lay or home use.
Device Story
Device consists of heat-conductive probe with internal thermistor connected to ESCORT II Patient Monitor via multiparameter module (MPM); disposable probe covers prevent cross-contamination. Operates in Normal (predictive) or Monitor (continuous) modes. Predictive algorithm processes thermistor signals to estimate patient temperature in 4-10 seconds. Used by healthcare practitioners in clinical/hospital settings. Output displayed on ESCORT II panel; assists clinicians in assessing patient thermal status. Benefits include rapid, accurate temperature determination and integration into existing patient monitoring workflows.
Clinical Evidence
Bench testing only. Evaluated accuracy and repeatability against predicates using Diatek technology. Testing included performance at environmental extremes and validation against a constant temperature source. Statistical analysis showed high correlation (r=0.999) and mean error of 0.000.
Technological Characteristics
Heat-conductive probe with internal thermistor; modular design for ESCORT II Patient Monitor. Connectivity via coiled cable to MPM. Power via monitor batteries or AC mains. Software-based predictive algorithm for temperature calculation. Disposable probe covers used for infection control.
Indications for Use
Indicated for intermittent or continuous temperature monitoring in hypothermic, normothermic, or febrile children and adults. For use by healthcare practitioners in hospital, clinic, or mobile settings. Not for home or lay use.
Regulatory Classification
Identification
A clinical electronic thermometer is a device used to measure the body temperature of a patient by means of a transducer coupled with an electronic signal amplification, conditioning, and display unit. The transducer may be in a detachable probe with or without a disposable cover.
Special Controls
(1) Device is not a clinical thermometer with telethermographic functions;
(2) Device is not a clinical thermometer with continuous temperature measurement functions; and
(3) Appropriate analysis and testing (such as that outlined in the currently FDA-recognized editions, as appropriate, of ISO 80601-2-56, “Medical electrical equipment—Part 2-56: Particular requirements for basic safety and essential performance of clinical thermometers for body temperature measurement,” or ASTM E1965, “Standard Specification for Infrared Thermometers for Intermittent Determination of Patient Temperature,” or ASTM E1112, “Standard Specification for Electronic Thermometer for Intermittent Determination of Patient Temperature,” or ASTM E1104, “Standard Specification for Clinical Thermometer Probe Covers and Sheaths”) must validate specifications and performance of the device.
Predicate Devices
- ESCORT II Patient Monitor with YSI temperature measurement capability
- Diatek SureTemp Thermometer System
- Welch Allyn LifeSign Critical Vital Signs Monitor (CVSM)
Related Devices
- K171182 — ri-former Predictive Thermometer · Rudolf Riester GmbH · Oct 4, 2017
- K223807 — Reusable Temperature Probe, Disposable Temperature Probe · Shenzhen Sino-K Medical Technology Co.,Ltd · Aug 25, 2023
- K050837 — REUSABLE TEMPERATURE PROBES (M1024254 SKIN TEMPERATURE PROBE, REUSABLE; M1024247, GP TEMPERATURE PROBE, ADULT, RESUABLE · GE Healthcare · Apr 27, 2005
- K030580 — SURETEMP PLUS · Welch Allyn, Inc. · May 6, 2003
- K203636 — PlusCare Temperature Probes, Skin Types: PT2252-AS, PTHP-AS, PTMQ-AS, PTSW-AS, PTSM-15AS, PTSL-AS, PTMR-AS; Rectum Types: PT2252-AG, PTHP-AG, PTMQ-AG, PTSW-AG, PTSM-15AG, PTSL-AG, PTMR-AG · Jkh USA, LLC · Aug 31, 2021
Submission Summary (Full Text)
{0}
K970011
JUL - 9 1997
# ESCORT® II
## CLINICAL THERMOMETRY MODULE
### 510(K) SUBMISSION
### 510(K) SUMMARY
{1}
K970011
# ESCORT® II Clinical Thermometry Module
## Submitted by:
David M. Trueblood
Regulatory Affairs Manager
Medical Data Electronics
12720 Wentworth Street
Arleta, California 91331
Telephone: 818-768-6411
Contact: David M. Trueblood
Date Prepared: December 31, 1996
## Device Name:
Trade Name: ESCORT® II Clinical Thermometry Module (CTM)
Common/Usual Name: Thermometer, Electronic Thermometer, Predictive Thermometer
Classification Name: Thermometer, Electronic, Clinical
## Substantial Equivalence:
The Clinical Thermometry Module (CTM) for the ESCORT® II Patient Monitor is substantially equivalent to the ESCORT II Patient Monitor with Yellow Springs Instruments (YSI) temperature measurement capability, to the Diatek® SureTemp® Thermometer System and to the Welch Allyn LifeSign® Critical Vital Signs Monitor (CVSM). The MDE Clinical Thermometry Module has the same intended use, has the same or equivalent design, materials, method of action and labeling and, therefore, is substantially equivalent to these and other clinical electronic thermometers currently distributed commercially in the United States. Temperature channels are factory-configured, as are all parameters contained in the MDE Multiparameter Module (MPM). Since hardware, software and function are identical in the CTM to those incorporated in the MPM, the CVSM and in the SureTemp®, which have all been previously granted marketing clearance by FDA, substantial equivalence to these devices is assured and claimed.
Medical Data Electronics, Inc.
12720 Wentworth St. Arleta, CA 91331-4329 (818) 768-6411 Fax (818) 768-4197
{2}
# Device Description:
The CTM consists of an elongated metal heat-conductive probe connected to the multiparameter module (MPM) which may be used with the ESCORT® II Patient Monitor through a coiled cable. The probe contains a thermistor which conveys temperature information to the MPM for calculation of patient temperature which may be displayed on the ESCORT® II display panel.
Prior to use, the probe is inserted into a plastic probe cover. The cover offers no significant barrier to heat transfer from the patient to the probe body. The disposable nature of the probe cover prevents microbiological cross-contamination among patients such as might occur with a reusable probe.
Calculation of patient temperature may, in the normal mode, utilize algorithms which enable accurate temperature prediction within 3 to 10 seconds of probe placement.
# Intended Use:
The Clinical Thermometry Module is intended to be used for the intermittent determination of temperature in hypothermic, normothermic or febrile children or adults. In the Normal mode, oral use in compliant patients allowing maintenance of the probe in the sublingual picket for the temperature-taking cycle, enables the predictive algorithm to determine an accurate temperature in approximately 4 seconds. Rectal use results in a predictive temperature in approximately 10 seconds.
# Comparison to Predicate Devices:
The Clinical Thermometry Module for use with the ESCORT II Patient Monitor is shown to demonstrate substantial equivalence to the ESCORT II Patient Monitor with YSI temperature measurement technology, to the Diatek® SureTemp® Thermometer System and the Welch Allyn LifeSign® Critical Vital Signs Monitor (CVSM).
The following table summarizes the characteristics of the four electronic thermometers.
{3}
| ITEM | CTM | CTM WITH YSI | SURETEMP® | LIFESIGN® |
| --- | --- | --- | --- | --- |
| Display Temperature Range | 84.0°F to 108.8°F
28.9°C to 42.2°C | 20° to 50°C | 84.0 to 108.8°F
28.9 to 42.2°C | 84.0 to 108.8°F
28.9 to 42.2°C |
| Laboratory Accuracy | ±0.2°F, in Monitor mode in a stirred water bath | ±0.1°C | ±0.2°F, in Monitor mode in a stirred water bath | per ASTM E-1112-86 |
| Precision | 0.1°F
0.1°C | Not Specified | 0.1°F
0.1°C | Not Specified |
| Operating Temperature Range | 60.8°F to 104°F
16°C to 40°C | 5°C to 40°C | 60.8°F to 104°F
16°C to 40°C | 82°F to 104°F
10°C to 40°C |
| Operating Humidity Range | 15% to 95%, non-condensing | 0 to 90%, non-condensing | 15% to 95%, non-condensing | 15% to 90%, non-condensing |
| Storage Temperature Range | -4°F to 120°F
-20°C to 50°C | -40°C to +70°C | -4°F to 120°F
-20°C to 50°C | -4°F to 122°F
-20°C to 50°C |
| Storage Humidity Range | 15% to 95%, non-condensing | 10 to 100%, non-condensing | 15% to 95%, non-condensing | 15% to 90%, non-condensing |
| Power Source | Modular Batteries; 2 each, 12V, 2.3 AH
AC Main: 115/230VAC, Selectable
48-62 Hz, Autosensing | Modular Batteries; 2 each, 12V, 2.3 AH
AC Main: 115/230VAC, Selectable
48-62 Hz, Autosensing | AA, Alkaline | Lead Acid |
| | AC Current: 0.4A @ 115VAC
0.2 A @ 230VAC | AC Current: 0.4A @ 115VAC
0.2 A @ 230VAC | N/A | AC Current: 120 VAC
220-240 VAC |
| | | | | |
| Battery Operating Life | 2.5 to 4 hours, depending on monitor configuration | 2.5 to 4 hours, depending on monitor configuration | About 6000 readings | 10 Hours, minimum |
{4}
# Device Testing:
Bench testing methods were utilized to confirm the accuracy and repeatability of the as referenced to the predicate devices containing the Diatek clinical electronic thermometer technology. The intent of the bench tests was: 1.) To exercise the CTM by making temperature measurements at operational environmental extremes of temperature and humidity to ensure system performance comparable to the predicate devices incorporating Diatek technology and, 2.) To validate the CTM against the predicate devices incorporating Diatek technology using a constant temperature source.
Results of statistical analysis of the bench test data are contained in the following tables.
| Simple Linear Regression Analysis: | | | | | |
| --- | --- | --- | --- | --- | --- |
| Slope: | 0.995 | r: | 0.999 | Mean Error: | 0.000 |
| Y-Intercept: | 0.0938 | SEE: | 0.5246 | Std. Deviation: | 0.0391 |
| Environmental Test Data | | | | | |
| Simple Linear Regression Analysis: | | | | | |
| --- | --- | --- | --- | --- | --- |
| Slope: | 1.000 | r: | 1.000 | Mean Error: | 0.000 |
| Y-Intercept: | 0.000 | SEE: | 0.000 | Std. Deviation: | 0.000 |
| Heat Well Test Data | | | | | |
# Conclusions of Bench Tests:
Results of bench testing confirm the accuracy of the CTM relative to two predicate devices utilizing the same proprietary technology. The results support the substantial equivalence claim for the CTM.
{5}
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
Mr. David M. Trueblood
Regulatory Affairs Manager
Medical Data Electronics, Incorporated
12720 Wentworth Street
Arleta, California 91331
JUL - 9 1997
Re: K970011
Trade Name: Escort II Clinical Thermometry Module (CTM)
Regulatory Class: II
Product Code: FLL
Dated: April 9, 1997
Received: April 10, 1997
Dear Mr. Trueblood:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531
{6}
Page 2 - Mr. Trueblood
through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4618. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Timothy A. Ulatowski
Director
Division of Dental, Infection Control and General Hospital Devices
Office of Device Evaluation
Center for Devices and Radiological Health
Enclosure
{7}
510(k) Number (if known): K970011
Device Name: ESCORT II CLINICAL THERMOMETRY MODULE (CTM)
Indications For Use:
The primary use of the CTM, as an intermittent thermometer, is to take a patient's temperature at a single point in time. However, the instrument's Monitor mode also allows continuous monitoring of the patient's temperature. The CTM is a clinical grade thermometer. It is intended for use by healthcare practitioners only; typically in a hospital, clinic or mobile environment. It is not intended for lay or home use.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CORH, Office of Device Evaluation (ODE)
(Division Sign-Off) Pictetree Cnuee
Division of Dental, Infection Control, and General Hospital Devices
510(k) Number K970011
Prescription Use: ☑
(Per 21 CFR 801.109)
Over-the-Counter Use: ☐
(Optional Format 1-2-96)